1Caixia T,Daming Z,Xiran L.Levels of beta-endorphin in theplasma and skin tissue fluids of patients with vitiligo[J].J DermatolSci,2001,26(1):62-66.
2Alkhateeb A,Fain PR,Thody A,et al.Epidemiology of Vitiligoand Associated Autoimmune Diseases in Caucasian Probands andTheir Familier[J].Pigment Cell Res,2003,16(3):208-214.
3Tanghetti EA.Tacrolimus ointment0.1%produces repigmentationin patients with vitiligo:results of a prospective patient series[J].Cutis,2003,71(2):158-162.
4Kawalek AZ,Spencer JM,Phelps RG.Combined excimer laserand topical tacrolimus for the treatment of vitiligo:a pilot study[J].Dermatol Surg,2004,30(2 Pt 1):130-135.
5Scherschun L,Kim JJ,Lim HW.Narrow-band ultraviolet B isa useful and well-tolerated treatment for vitiligo[J].J Am AcadDermatol,2001,44(6):999-1003.
6Kose O,Riza Gur A,Kurumlu Z,et al.Calcipotriol ointment versusclobetasol ointment in localized vitiligo:an open,comparative clinicaltrial[J].Int J Dermatol,2002,41(9):616-618.
